NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Adeptus Health Inc. (NYSE:ADPT). Our investigation concerns whether Adeptus and certain of its officers and/or directors have violated federal securities laws and/or engaged in other unlawful business practices.
On March 2, 2017, Adeptus filed a Form NT 10-K with the U.S. Securities & Exchange Commission, stating that the Company would postpone the filing of its 2016 annual report. The Company revealed that it had identified “material weaknesses with respect to internal control over financial reporting in the areas of revenue recognition, accounts receivable, accounting for a contribution to an unconsolidated joint venture, and accounting for equity in (loss) earnings of unconsolidated joint ventures.”
Following this news, Adeptus shares fell $3.76 per share, or approximately 57.4%, to close at $2.79 per share on March 2, 2017.
If you purchased or otherwise acquired Adeptus securities and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact J. Brandon Walker, Esq. by email at firstname.lastname@example.org, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation into Adeptus, please go to www.bespc.com/adeptus-health-inc. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.